XML 51 R35.htm IDEA: XBRL DOCUMENT v3.8.0.1
Restructuring and Contract Terminaiton Charges, Net (Tables)
 12 Months Ended
Dec. 31, 2017
Restructuring and Related Activities [Abstract]  
Restructuring and Related Costs [Table Text Block]
The following table summarizes the number of employees reduced, the initial restructuring or contract termination charges by operating segment, and the dates by which payments were substantially completed, or the expected dates by which payments will be substantially completed, for restructuring actions implemented during fiscal years 2017, 2016 and 2015 in continuing operations:
 
Workforce Reductions
 
Closure of Excess Facility
 
Total
 
(Expected) Date Payments Substantially Completed by
 
Headcount Reduction
 
Diagnostics
 
Discovery & Analytical Solutions
 
Diagnostics
 
Discovery & Analytical Solutions
 
 
Severance
 
Excess Facility
 
(In thousands, except headcount data)
 
 
 
 
Q4 2017 Plan

29

 
$
255

 
$
1,680

 
$
—

 
$
—

 
$
1,935

 
Q1 FY2019
 
—
Q3 2017 Plan

27

 
1,021

 
1,321

 
—

 
—

 
2,342

 
Q4 FY2018
 
—
Q1 2017 Plan

90

 
1,631

 
5,000

 
33

 
33

 
6,697

 
Q2 FY2018
 
Q2 FY2018
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Q3 2016 Plan

22

 
41

 
1,779

 
—

 
—

 
1,820

 
Q4 FY2017
 
—
Q2 2016 Plan

72

 
561

 
4,106

 
—

 
—

 
4,667

 
Q3 FY2017
 
—
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Q4 2015 Plan
174

 
1,315

 
9,980

 
—

 
285

 
11,580

 
Q1 FY2017
 
Q4 FY2017
Q2 2015 Plan
95

 
673

 
5,290

 
—

 
—

 
5,963

 
Q2 FY2016
 
—
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]
The following table summarizes the Company's restructuring accrual balances and related activity by restructuring plan, as well as contract termination accrual balances and related activity, during fiscal years 2017, 2016 and 2015 in continuing operations:

 
 
Balance at December 28, 2014
 
2015 Charges and Changes in Estimates, Net
 
2015 Amounts Paid
 
Balance at January 3, 2016
 
2016 Charges and Changes in Estimates, Net
 
2016 Amounts Paid
 
Balance at January 1, 2017
 
2017 Charges and Changes in Estimates, Net
 
2017 Amounts Paid
 
Balance at December 31, 2017
 
(In thousands)
 
 
 
 
 
 
Severance:
 
 
 
 
 
 
 
 
 
 
 
 
Q4 2017 Plan

 
$
—

 
$
—

 
$
—

 
$
—

 
$
—

 
$
—

 
$
—

 
$
1,935

 
$
(16
)
 
$
1,919

Q3 2017 Plan

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
2,342

 
(270
)
 
2,072

Q1 2017 Plan

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
6,631

 
(4,133
)
 
2,498

Q3 2016 Plan
 
—

 
—

 
—

 
—

 
1,820

 
(612
)
 
1,208

 
(202
)
 
(1,006
)
 
—

Q2 2016 Plan(1)
 
—

 
—

 
—

 
—

 
4,667

 
(3,231
)
 
1,436

 
(829
)
 
(607
)
 
—

Q4 2015 Plan(2)
 
—

 
11,295

 
(925
)
 
10,370

 
(953
)
 
(8,198
)
 
1,219

 
(1,066
)
 
(153
)
 
—

Q2 2015 Plan
 
—

 
5,423

 
(4,322
)
 
1,101

 
(533
)
 
(370
)
 
198

 
(198
)
 
—

 
—

 
 
 
 
 
 
 
 
 
 
 
 
 
 


 
 
 
 
 
 
Facility:
 
 
 
 
 


 
 
 
 
 
 
Q1 2017 Plan

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
66

 
(33
)
 
33

Q4 2015 Plan
 
—

 
285

 
(26
)
 
259

 
—

 
(248
)
 
11

 
—

 
—

 
11

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Previous Plans(3)
 
23,522

 
(3,539
)
 
(9,695
)
 
10,288

 
35

 
(3,971
)
 
6,352

 
727

 
(2,691
)
 
4,388

Restructuring
 
23,522

 
13,464

 
(14,968
)
 
22,018

 
5,036

 
(16,630
)
 
10,424

 
9,406

 
(8,909
)
 
10,921

Contract Termination
 
304

 
83

 
(255
)
 
132

 
88

 
(103
)
 
117

 
3,251

 
(320
)
 
3,048

Total Restructuring and Contract Termination
 
$
23,826

 
$
13,547

 
$
(15,223
)
 
$
22,150

 
$
5,124

 
$
(16,733
)
 
$
10,541

 
$
12,657

 
$
(9,229
)
 
$
13,969

____________________________
(1) 
During fiscal year 2017, the Company recognized pre-tax restructuring reversals of $0.4 million each in the Discovery & Analytical Solutions and Diagnostics segments, related to lower than expected costs associated with workforce reductions for the Q2 2016 Plan.
(2) 
During fiscal year 2017, the Company recognized pre-tax restructuring reversals of $0.5 million each in the Discovery & Analytical Solutions and Diagnostics segments related, to lower than expected costs associated with workforce reductions for the Q4 2015 Plan.
(3) 
During fiscal year 2017, the Company recognized pre-tax restructuring charges of $0.3 million in the Discovery & Analytical Solutions and $0.4 million in the Diagnostics segments related to change in lease assumptions partially offset by lower than expected costs associated with workforce reductions for the Previous Plans.